According to Haemonetics's latest financial reports the company has $0.19 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $0.28 B | 9.62% |
2022-03-31 | $0.25 B | 34.94% |
2021-03-31 | $0.19 B | 40.05% |
2020-03-31 | $0.13 B | -18.92% |
2019-03-31 | $0.16 B | -6% |
2018-03-31 | $0.18 B | 29.09% |
2017-03-31 | $0.13 B | 21.23% |
2016-03-31 | $0.11 B | -28.34% |
2015-03-31 | $0.16 B | -16.53% |
2014-03-31 | $0.19 B | 7.45% |
2013-03-31 | $0.17 B | -21.73% |
2012-03-31 | $0.22 B | 16.35% |
2011-03-31 | $0.19 B | 38.95% |
2010-03-31 | $0.14 B | -9.67% |
2009-03-31 | $0.15 B | 17.35% |
2008-03-31 | $0.13 B | -41.74% |
2007-03-31 | $0.22 B | -8.55% |
2006-03-31 | $0.25 B | 34.9% |
2005-03-31 | $0.18 B | 57.31% |
2004-03-31 | $0.11 B | 136.78% |
2003-03-31 | $49.88 M | -26.15% |
2002-03-31 | $67.54 M | -9.31% |
2001-03-31 | $74.48 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $26.21 B | 13,415.97% | ๐บ๐ธ USA |
Medtronic MDT | $8.32 B | 4,189.66% | ๐ฎ๐ช Ireland |
Thermo Fisher Scientific TMO | $8.07 B | 4,063.87% | ๐บ๐ธ USA |
Baxter BAX | $3.02 B | 1,459.97% | ๐บ๐ธ USA |
Becton Dickinson BDX | $1.18 B | 509.35% | ๐บ๐ธ USA |
Stryker Corporation SYK | $2.40 B | 1,140.86% | ๐บ๐ธ USA |
PerkinElmer
PKI | $2.46 B | 1,168.78% | ๐บ๐ธ USA |
Cerus CERS | $65.85 M | -66.05% | ๐บ๐ธ USA |